4.7 Article

The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML

Julia E. Maxson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srdan Verstovsek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Claire Harrison et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Hematology

G-CSF and its receptor in myeloid malignancy

Renee Beekman et al.

Article Oncology

Characterization of murine JAK2V617F-positive myeloproliferative disease

Thomas G. P. Bumm et al.

CANCER RESEARCH (2006)